Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
Each week we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
NEW YORK (Reuters Health) – In patients with chronic stable heart failure (HF) due to nonischemic dilated cardiomyopathy, a year’s treatment with n-3 polyunsaturated fatty acids (n-3 PUFAs)…
NEW YORK (Reuters Health) – Anticoagulation with low-molecular-weight heparin (LMWH) dalteparin following heart valve surgery leads to fewer adverse events than does unfractionated heparin, Canadian researchers report in…
NEW YORK (Reuters Health) – Alpha-blockers and antibiotics relieve symptoms of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) better than other therapies, according to a network meta-analysis in the…
Rosuvastatin should be considered for HIV-positive people with dyslipidemia — and guidelines should be updated to reflect that, suggests a new study. Although guidelines from the Infectious Diseases…
NEW YORK (Reuters Health) – In patients with atrial fibrillation, strict heart rate control provides no advantage over more lenient control, according to a focused update of the…
NEW YORK (Reuters Health) – Protease inhibitors do not prevent complications associated with endoscopic retrograde cholangiopancreatography (ERCP), researchers from Japan report in the December 8th Gastrointestinal Endoscopy. Previous…
NEW YORK (Reuters Health) – Spironolactone use is associated with improved long-term survival in patients with systolic heart failure, researchers from Japan report in the December American Heart…
NEW YORK (Reuters Health) – Recombinant surfactant protein C based surfactant (rSP-C, Nycomed) provides no benefit in patients with severe direct lung injury, but the information gained may…
NEW YORK (Reuters Health) – By restoring cognitive function in patients with minimal hepatic encephalopathy (MHE), rifaximin treatment also improves their quality of life, investigators in India report.…
NEW YORK (Reuters Health) – In children with chronic uveitis, adalimumab appears more effective than infliximab in maintaining remission, according to a small cohort study by Italian investigators.…
